Mark Adamchak - 14 Mar 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Principal Accounting Officer
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
14 Mar 2025
Net transactions value
$0
Form type
4
Filing time
18 Mar 2025, 18:45:45 UTC
Previous filing
19 Feb 2025
Next filing
03 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Award $0 +3,029 $0.000000 3,029 14 Mar 2025 Common Stock 3,029 $3.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option vest on the one-year anniversary of the grant date.